FDA Warns Companies to Stop Making MRSA Claims for OTC Products

The U.S. Food and Drug Administration issued four warning letters to companies that manufacture and market over-the-counter drug products, including hand sanitizers, that claim to prevent infection from MRSA.

Advertisement

The FDA warning letters were sent to the following firms:

•    Tec Laboratories for Staphaseptic First Aid Antiseptic/Pain Relieving Gel
•    JD Nelson and Associates for Safe4Hours Hand Sanitizing Lotion and Safe4Hours First Aid Antiseptic Skin Protectant
•    Dr. G.H. Tichenor Antiseptic Co. for Dr. Tichenor’s Antiseptic Gel
•    Oh So Clean/CleanWell Company for CleanWell All-Natural Foaming Hand Sanitizer, CleanWell All-Natural Hand Sanitizer, CleanWell All-Natural Hand Sanitizing Wipes and CleanWell All-Natural Antibacterial Foaming Handsoap

Labeling and marketing materials for these products also claim that they can prevent infection from other disease-causing agents. In addition, the labeling of some of the firms’ hand sanitizing drug products make claims related to preventing infection from E. coli and/or H1N1 flu virus. The FDA does not have sufficient evidence demonstrating that these products are safe and effective for these purposes.

The companies have 15 days to correct the violations cited in the warning letters. Failure to do so may result in legal action including seizure and injunction.

Read the FDA news release about its warning letters for OTC products claiming protection against MRSA.

Read other coverage about MRSA:

Study: No Advantage in Only Screening and Identifying MRSA in Hospital ICUs

Wound Dressing With Silver Kills MRSA, Other Antibiotic-Resistance ‘Superbugs’

New Website Ranks Maine Healthcare Providers Based on Quality of Care

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

  • As the ASC industry continues to grow alongside new waves of surgical innovation, patient preferences and shifts to value-based care,…

  • A Pleasant View, Utah-based physician has been indicted on charges of obtaining unapproved drugs from China and selling them to…

  • From payer obstacles to operational pressures, five ASC leaders discuss the biggest frictions they’re facing. Note: Responses were lightly edited.…

Advertisement

Comments are closed.